Skip to main content
. 2022 May 16;16:1390. doi: 10.3332/ecancer.2022.1390

Table 2. Incidence and severity of HFS and its correlation with WHO and NCI CTCAE 5.0 scores.

Severity WHO NCI/CTCAE 5.0 Number of patients %
Mild Grade I: Dysesthesia/paresthesia, tingling in hands and feet. Grade I: Minimal skin changes or dermatitis (erythema, oedema and hyperkeratosis), no pain. 11 73.30
Moderate Grade II: Discomfort when walking and/or holding objects, pain, erythema and oedema. Grade II: Moderate skin changes (scaling, blisters, bleeding, cracking and erosion) with pain, relative limitation. 3 20
Severe Grade III: Painful swelling and erythema in hands and feet and around the fingernails and toenails. Grade III: Severe skin changes (scaling, blisters, bleeding, fissures, erosions and hyperkeratosis) with pain. 1 6.70
Grade IV: Erosion, ulceration, blisters and severe pain. _ 0 0